CTRI/2020/07/026410Not yet recruitingPhase 2
A Randomized Control Open Label Clinical Trial On The Efficacy Of Shatapushpa Churna And Madhutailika Basti In Nashtartava w.s.r. To Polycystic Ovarian Syndrome
ational Institute of Ayurveda Jaipur0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients willing to give voluntary informed consent.
- •Both married and unmarried patients.
- •ASRM/ESHRE (Rotterdam) Criteria,2013- Affected individuals must have two out of three criteria
- •1. Oligo and /or anovulation
- •2. Hyperandrogenism (clinical and /or biochemical).
- •3. Polycystic ovaries(Confirmed on USG).
Exclusion Criteria
- •Patients not willing to give voluntary informed consent.
- •Women of age <18years and >40years.
- •Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, diabetes mellitus, Tuberculosis etc.).
- •Patients using oral contraceptive pills.
- •Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ.
- •Any type of malignancy.
- •Patients with positive Sexually transmitted diseases (STDs), Human Immunodeficiency Virus HIV, Hepatitis B Surface Antigen(HbsAg).
- •Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Trial to see effectiveness Of Nasal Administration of Vacha Pippali Oil and oral medication in Ardhavbhedak wsr MigraineCTRI/2023/02/049845Poonam Bamola
Completed
Phase 2
An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19CTRI/2020/06/025768ational Institute of Siddha215
Active, not recruiting
Phase 1
Clinical Trial of vedolizumab versus conventional treatment for Checkpoint Inhibitor induced ColitisImmune check point inhibitor induced colitisMedDRA version: 22.0Level: LLTClassification code 10082455Term: Immune-mediated colitisSystem Organ Class: 100000004856EUCTR2020-005793-10-DKJakob Benedict Seidelin76
Not yet recruiting
Phase 2
A clinical trial to evaluate the effect of dhatri lauha in the management of garbhini pandu (iron deficiency anemia)CTRI/2020/02/023577All india institute of ayurveda
Not yet recruiting
Phase 2
A clinical trial to evaluate the effect of Shatavari ghrita on fetal outcome w.s.r. to birth weightCTRI/2020/02/023448All India Institute Of Ayurveda